IFLR is part of Legal Benchmarking Limited, 1-2 Paris Garden, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement


This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
85 results85 results
1
of
5
Deal Highlights
34 results34 results
Deal Name Deal Date Firm Name Jurisdiction Deal Type Lawyer Names Client Names Client Role
ASM Pacific Technology - Joint venture
2020-12-28
Fangda Partners
Hong Kong SAR
Joint venture
Ke Lu, Raymond Chan
ASM Pacific Technology
Joint venture partner
JW (Cayman) Therapeutics - IPO
2020-11-03
Fangda Partners
Hong Kong SAR
IPO
Colin Law, Edward Bong
JW (Cayman) Therapeutics
Issuer
WuXi Biologics - Secondary share offering
2021-02-25
Fangda Partners
Hong Kong SAR
Secondary share offering
Colin Law, Arman Lie
WuXi Biologics
Issuer
Morgan Stanley; Huatai; J.P. Morgan; Goldman Sachs - Secondary share offering
2020-08-05
Fangda Partners
Hong Kong SAR
Secondary share offering
Colin Law, Arman Lie, Christine Chen
Morgan Stanley, Huatai, J.P. Morgan, Goldman Sachs
Issuer
Jinxin Fertility - Secondary share offering
2021-02-09
Fangda Partners
Hong Kong SAR
Secondary share offering
Colin Law, Arman Lie
Jinxin Fertility
Issuer
Fengxiang Company - Secondary share offering
2020-07-16
Fangda Partners
Hong Kong SAR
Secondary share offering
Christina Fu, Arnold Pang
Fengxiang Company
Issuer
BOCOM International (Asia) - Secondary share offering
2020-07-13
Fangda Partners
Hong Kong SAR
Secondary share offering
Peter Chen
BOCOM International (Asia)
Issuer
Ant Group - IPO
2020-11-03
Fangda Partners
Hong Kong SAR
IPO
Christina Fu
Ant Group
Issuer
Cheshi Holdings - IPO
2021-01-15
Fangda Partners
Hong Kong SAR
IPO
Arnold Pang, Christina Fu
Cheshi Holdings
Issuer
Haina Intel - IPO
2020-06-03
Fangda Partners
Hong Kong SAR
IPO
Arnold Pang
Haina Intel
Issuer
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co - Secondary share offering
2020-06-18
Fangda Partners
Hong Kong SAR
Secondary share offering
Christina Fu
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co
Issuer
C-MER Eye Care - Secondary share offering
2020-06-30
Fangda Partners
Hong Kong SAR
Secondary share offering
Arnold Pang
C-MER Eye Care
Issuer
HOPU Jinghua (Beijing) Investment Consultancy Co - Fund raising
2020-03-15
Fangda Partners
Hong Kong SAR
Fund raising
Mark Lehmkuhler, Tianyi Chen
HOPU Jinghua (Beijing) Investment Consultancy Co
Investor
Keqiao (HK) International Investment Co Ltd - Bond Issue
2022-03-01
Fangda Partners
Hong Kong SAR
Bond issue
Keqiao (HK) International Investment Co Ltd
Issuer
2
of
2
IFLR’s legal benchmarking title launches its latest national and regional rankings for China, spanning 157 firms and 91 newly ranked players
While the emerging industry is set to grow, strict regulatory scrutiny can be expected
The Hong Kong Stock Exchange wants to better connect China with the rest of the world but investors are asking for further change
Proposed rules screen out less credible issuers but will lead to more delays and uncertainty around deals
IFLR1000
Red circle firm makes first Beijing partner hire of 2021
IFLR1000
View winners for deals, firms, lawyers and teams of the year for China
IFLR1000
您可在线查看本年度最佳交易、律师事务所、律师和团队的名单
IFLR1000
Shortlists for deals, firms, individuals and teams of the year available to view online
Sponsored